Basel Area reaches new milestone with settlement of LifeMine
The American life sciences company LifeMine Therapeutics is building its European headquarters in the Basel region. Basel Area Business & Innovation has now supported exactly 200 companies in settling in the cantons of Basel-Stadt, Basel-Landschaft and Jura.
Basel Area Business & Innovation , the agency for location promotion and innovation promotion, has reached a new milestone. With LifeMine Therapeutics , the 200th company has now been supported in settling in the Basel area. The biotechnology company has its headquarters in Cambridge in the US state of Massachusetts and is now establishing its European headquarters in the Basel Area, which consists of the three cantons of Basel-Stadt, Basel-Landschaft and Jura.
“Having LifeMine Therapeutics as our 200th customer is very exciting for our team and the region,” said Christof Klöpper, CEO of Basel Area Business & Innovation. “The fact that LifeMine Therapeutics comes from the Boston Area – one of the world’s largest life sciences centers – underscores the opportunities that the Basel Area offers international biotech companies.”
LifeMine develops drugs based on genetically encoded small molecules and will now also drive this work from Basel. “We are very pleased to be able to expand our activities to Basel and settle in a region full of innovative companies,” says co-founder and Chief Operating Officer (COO) WeiQing Zhou. “Basel Area Business & Innovation gave us fantastic support and made the process as smooth as we could have wished for.”
Of the 200 companies supported by Basel Area since 2016, 164 are not from Switzerland. A total of 122 work in the life sciences. In the meantime, however, more and more companies from the production and process technology sectors are deciding to settle in the Basel area.